Endocrine complications are frequently observed in childhood cancer survivors (CCS). One of two CCS will experience at least one endocrine complication during the course of his/her lifespan, most commonly as a late-effect of cancer treatments, especially radiotherapy and alkylating agent chemotherapy. Endocrine late-effects include impairments of the hypothalamus/pituitary, thyroid and gonads, as well as decreased bone mineral density and metabolic derangements leading to obesity and/or diabetes mellitus. A systematic approach where CCS are screened for endocrine late-effects based on their cancer history and treatment exposures may improve health outcomes by allowing the early diagnosis and treatment of these complications.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1530/EJE-17-0054 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Endocrine dysfunction in long-term survivors of pediatric head and neck rhabdomyosarcoma.
Eur J Endocrinol
January 2025
Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Objective: Survivors of pediatric head and neck rhabdomyosarcoma (HNRMS) are at risk of developing endocrinopathies following local treatment, resulting from radiation damage to the pituitary gland, hypothalamus, or thyroid gland, often at a young age. Our aim was to determine the prevalence of endocrine dysfunction in long-term HNRMS survivors and compare the prevalence of anterior pituitary insufficiency (API) among different local treatment strategies: external beam radiation with photons, external beam radiation with protons, microscopically radical surgery combined with external irradiation, and macroscopic radical surgery combined with brachytherapy.
Design And Methods: Head and neck rhabdomyosarcoma survivors treated between 1993 and 2017, with ≥2 years of follow-up, without recurrent disease or secondary malignancy were eligible for this study.
Immediate improvement in patient care: Auditing adherence to the British Society for Haematology guidelines on screening and management of the long-term consequences of multiple myeloma and treatment.
EJHaem
December 2024
Department of Haematology Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK.
Advances in myeloma have resulted in improved prognosis for patients. However complications of the disease and treatment, pose a risk of specific long-term consequences. An audit tool was adapted to assess adherence to the British Society for Haematology guidelines for screening and management of long-term myeloma consequences.
View Article and Find Full Text PDFLong-term impact of embryonic exposure to ethinylestradiol and clotrimazole on behavior and neuroplasticity in zebrafish (Danio rerio).
Environ Toxicol Pharmacol
January 2025
MARBEC, University of Montpellier, CNRS, Ifremer, IRD, INRAE, Palavas-les-Flots, France. Electronic address:
Estrogen receptors (ER) are widely expressed in the brain of many species and experimental results highlighted the role of estradiol in neuronal plasticity and behavior. Consequently, the brain is therefore a prime target for endocrine disrupting chemicals (EDCs) interacting with estrogen signaling. Very little is known about the late effects of early disruption of estrogen signaling by EDCs.
View Article and Find Full Text PDFLong-term quality of survival after pediatric low-grade glioma.
Childs Nerv Syst
October 2024
Department of Neuro-Oncology, Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584CS, Utrecht, Netherlands.
Article Synopsis
- Low-grade glioma is the most common type of brain tumor in children, often leading to chronic issues due to residual tumors and treatment-related brain injury.
- Research highlights various affected areas like motor skills, speech, organ function, and psychosocial well-being, indicating the complexity of long-term effects.
- Understanding these affected domains is crucial for tailoring medical follow-ups, support strategies, and long-term care for survivors of childhood low-grade glioma.
Prenatal phthalate exposure and pubertal development in 16-year-old daughters: reproductive hormones and number of ovarian follicles.
Hum Reprod
November 2024
Department of Growth and Reproduction, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Article Synopsis
- The study investigates the potential links between maternal phthalate exposure during pregnancy and reproductive health outcomes in their teenage daughters, particularly focusing on hormone levels and reproductive anatomy indicators.
- Subtle associations were found between the levels of phthalate metabolites in prenatal samples and reproductive hormone levels (LH and IGF-1) and uterine volume measured 16 years later.
- The research involved 317 teenage daughters from a longitudinal study, assessing their development through hormonal analysis and ultrasound to evaluate ovarian and uterine health.*
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!